LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
96901-4
|
MDS v3.0 - RAI v1.17.2 - Delirium
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Delirium during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96902-2
|
MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96903-0
|
MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96904-8
|
MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96905-5
|
MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96906-3
|
MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96907-1
|
MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96908-9
|
MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.70
|
2.7
|
9690-9
|
Chromium
|
MCnc
|
Pt
|
XXX
|
Qn
| null |
DRUG/TOX
| 1 |
Chromium [Mass/volume] in Specimen
|
Chromium Spec-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96909-7
|
Cenobamate
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
|
Confirm
|
DRUG/TOX
| 1 |
Cenobamate [Mass/volume] in Serum or Plasma by Confirmatory method
|
Cenobamate SerPl Cfm-mCnc
| null |
ACTIVE
|
2.70
|
2.7
|
96910-5
|
Acanthamoeba sp & Naegleria fowleri & Balamuthia mandrillaris DNA panel
|
-
|
Pt
|
XXX
|
-
| null |
PANEL.MICRO
| 1 |
Acanthamoeba sp and Naegleria fowleri and Balamuthia mandrillaris DNA panel - Specimen
|
Free-living amoeba Pnl Spec
| null |
ACTIVE
|
2.70
|
2.7
|
96911-3
|
Delta aminolevulinate & porphobilinogen panel
|
-
|
Pt
|
Ser/Plas
|
-
| null |
PANEL.CHEM
| 1 |
Delta aminolevulinate and porphobilinogen panel - Serum or Plasma
|
D-ALA + PBG Pnl SerPl
| null |
ACTIVE
|
2.70
|
2.7
|
96912-1
|
CT global noise
|
Rden
|
Pt
|
Study
|
Qn
|
Calculated
|
RAD
| 2 |
Calculated CT global noise
|
Calc CT global noise
| null |
ACTIVE
|
2.70
|
2.7
|
96913-9
|
CT size-adjusted dose
|
EngCnt
|
Pt
|
Study
|
Qn
|
Calculated
|
RAD
| 2 |
Calculated CT size-adjusted dose
|
Calc CT size-adj dose
| null |
ACTIVE
|
2.70
|
2.7
|
96914-7
|
CT dose & image quality category
|
Type
|
Pt
|
Study
|
Nom
| null |
RAD
| 2 |
CT dose and image quality category
|
CT dose + image qual
| null |
ACTIVE
|
2.70
|
2.7
|
96915-4
|
CT quality measure out of range
|
Find
|
Pt
|
Study
|
Ord
| null |
RAD
| 2 |
CT quality measure out of range
|
CT qual meas out of range
| null |
ACTIVE
|
2.70
|
2.7
|
96916-2
|
Average diameter on axial mid-scan image
|
Len
|
Pt
|
^Patient
|
Qn
|
CT
|
RAD
| 2 |
CT Average diameter on axial mid-scan image
|
CT Avg diam axial mid-scan
| null |
ACTIVE
|
2.70
|
2.7
|
9691-7
|
Cobalt
|
MCnc
|
Pt
|
XXX
|
Qn
| null |
DRUG/TOX
| 1 |
Cobalt [Mass/volume] in Specimen
|
Cobalt Spec-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
96917-0
|
Average diameter on frontal scout image
|
Len
|
Pt
|
^Patient
|
Qn
|
CT
|
RAD
| 2 |
CT Average diameter on frontal scout image
|
CT Avg diam frontal scout
| null |
ACTIVE
|
2.70
|
2.7
|
96918-8
|
Fodrin.alpha subunit Ab.IgA
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
Fodrin alpha subunit IgA Ab [Units/volume] in Serum or Plasma by Immunoassay
|
Fodrin alpha IgA SerPl IA-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
96919-6
|
Nuclear Ab pattern.homogeneous
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Homogenous nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA Homogen Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96920-4
|
Nuclear Ab pattern.nucleolar
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Nucleolar nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA nucleolar Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96921-2
|
Nuclear Ab pattern.speckled
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Speckled nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA Speckled Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96922-0
|
Nuclear Ab pattern.spindle fibers
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Spindle fibers nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA spindle fibers Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96923-8
|
Nuclear Ab pattern.smooth nuclear envelope
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Smooth nuclear envelope nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA smooth nucl env Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96924-6
|
Nuclear Ab pattern.intercellular bridge
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Intercellular bridge nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA intercell bridge Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
9692-5
|
Isobutanol
|
MCnc
|
Pt
|
XXX
|
Qn
| null |
DRUG/TOX
| 1 |
Isobutanol [Mass/volume] in Specimen
|
Isobutanol Spec-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
96925-3
|
Nuclear Ab pattern.nuclear dots
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Nuclear dots nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA nuclear dots Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96926-1
|
PCNA extractable nuclear Ab
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
PCNA extractable nuclear Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ENA PCNA Ab Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96927-9
|
Nuclear Ab pattern.centrosomal
|
Titr
|
Pt
|
CSF
|
Qn
|
IF
|
SERO
| 1 |
Centrosomal nuclear Ab pattern [Titer] in Cerebral spinal fluid by Immunofluorescence
|
ANA centrosomal Titr CSF IF
| null |
ACTIVE
|
2.70
|
2.7
|
96928-7
|
Fodrin.alpha subunit Ab.IgG
|
ACnc
|
Pt
|
Ser/Plas
|
Qn
|
IA
|
SERO
| 1 |
Fodrin alpha subunit IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
|
Fodrin alpha IgG SerPl IA-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
96929-5
|
Personal well-being panel
|
-
|
Pt
|
^Patient
|
-
|
R-Outcomes
|
PANEL.SURVEY.R-OUTCOMES
| 4 |
Personal well-being panel [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.72
|
96930-3
|
Personal well-being score
|
Score
|
Pt
|
^Patient
|
Qn
|
R-Outcomes
|
SURVEY.R-OUTCOMES
| 4 |
Personal well-being score [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.7
|
96931-1
|
How are you feeling in general: I am satisfied with my life
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How are you feeling in general: I am satisfied with my life
| null | null |
ACTIVE
|
2.70
|
2.7
|
96932-9
|
How are you feeling in general: what I do in my life is worthwhile
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How are you feeling in general: What I do in my life is worthwhile
| null | null |
ACTIVE
|
2.70
|
2.7
|
9693-3
|
Mercury
|
MCnc
|
Pt
|
CSF
|
Qn
| null |
DRUG/TOX
| 1 |
Mercury [Mass/volume] in Cerebral spinal fluid
|
Mercury CSF-mCnc
| null |
ACTIVE
|
1.0i
|
2.7
|
96933-7
|
How are you feeling in general: I was happy yesterday
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How are you feeling in general: I was happy yesterday
| null | null |
ACTIVE
|
2.70
|
2.7
|
96934-5
|
How are you feeling in general: I was not anxious yesterday
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How are you feeling in general: I was not anxious yesterday
| null | null |
ACTIVE
|
2.70
|
2.7
|
96935-2
|
Heart rate
|
NRat
|
XXX^min
|
Arterial system
|
Qn
|
Pedometer
|
HRTRATE.MOLEC
| 2 |
Heart rate unspecified time minimum by Pedometer
|
Heart rate ?Tm Min Pedometer
| null |
ACTIVE
|
2.70
|
2.7
|
96936-0
|
Person-specific outcome panel
|
-
|
Pt
|
^Patient
|
-
|
R-Outcomes
|
PANEL.SURVEY.R-OUTCOMES
| 4 |
Person-specific outcome panel [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.7
|
96937-8
|
Issue you would like help with
|
Find
|
Pt
|
^Patient
|
Nom
| null |
SURVEY.R-OUTCOMES
| 4 |
Issue you would like help with
| null | null |
ACTIVE
|
2.70
|
2.7
|
96938-6
|
How much concern does the issue you would like help with cause
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How much concern does the issue you would like help with cause
| null | null |
ACTIVE
|
2.70
|
2.7
|
96939-4
|
Social contact panel
|
-
|
Pt
|
^Patient
|
-
|
R-Outcomes
|
PANEL.SURVEY.R-OUTCOMES
| 4 |
Social contact panel [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.73
|
96940-2
|
Social contact score
|
Score
|
Pt
|
^Patient
|
Qn
|
R-Outcomes
|
SURVEY.R-OUTCOMES
| 4 |
Social contact score [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.73
|
9694-1
|
Propoxur
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Propoxur [Mass/volume] in Serum or Plasma
|
Propoxur SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96941-0
|
Thinking about your friends and family: I have people to talk to
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about your friends and family: I have people to talk to
| null | null |
ACTIVE
|
2.70
|
2.7
|
96942-8
|
Thinking about your friends and family: I have someone I can confide in
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about your friends and family: I have someone I can confide in
| null | null |
ACTIVE
|
2.70
|
2.7
|
96943-6
|
Thinking about your friends and family: I have people who will help me
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about your friends and family: I have people who will help me
| null | null |
ACTIVE
|
2.70
|
2.7
|
96944-4
|
Thinking about your friends and family: I do things with others
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about your friends and family: I do things with others
| null | null |
ACTIVE
|
2.70
|
2.7
|
96945-1
|
Health confidence panel
|
-
|
Pt
|
^Patient
|
-
|
R-Outcomes
|
PANEL.SURVEY.R-OUTCOMES
| 4 |
Health confidence panel [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.72
|
96946-9
|
Health confidence score
|
Score
|
Pt
|
^Patient
|
Qn
|
R-Outcomes
|
SURVEY.R-OUTCOMES
| 4 |
Health confidence score [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.7
|
96947-7
|
How do you feel about caring for your health: I can look after my health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How do you feel about caring for your health: I can look after my health
| null | null |
ACTIVE
|
2.70
|
2.7
|
96948-5
|
How do you feel about caring for your health: I can get the right help if I need it
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How do you feel about caring for your health: I can get the right help if I need it
| null | null |
ACTIVE
|
2.70
|
2.7
|
96949-3
|
How do you feel about caring for your health: I am involved in decisions about me
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How do you feel about caring for your health: I am involved in decisions about me
| null | null |
ACTIVE
|
2.70
|
2.7
|
96950-1
|
How do you feel about caring for your health: I know enough about my health
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
How do you feel about caring for your health: I know enough about my health
| null | null |
ACTIVE
|
2.70
|
2.7
|
96951-9
|
Social determinants of health panel
|
-
|
Pt
|
^Patient
|
-
|
R-Outcomes
|
PANEL.SURVEY.R-OUTCOMES
| 4 |
Social determinants of health panel [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.72
|
96952-7
|
Social determinants of health score
|
Score
|
Pt
|
^Patient
|
Qn
|
R-Outcomes
|
SURVEY.R-OUTCOMES
| 4 |
Social determinants of health score [R-Outcomes]
| null |
Copyright © 2008-2021 R-Outcomes Ltd. All rights reserved.Users should notify Tim Benson by email: tim.benson@r-outcomes.com Used with permission
|
ACTIVE
|
2.70
|
2.7
|
96953-5
|
Thinking about how you live: I have had a good education
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about how you live: I have had a good education
| null | null |
ACTIVE
|
2.70
|
2.7
|
96954-3
|
Thinking about how you live: I am valued for what I do
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about how you live: I am valued for what I do
| null | null |
ACTIVE
|
2.70
|
2.7
|
96955-0
|
Thinking about how you live: I am happy about where I live
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about how you live: I am happy about where I live
| null | null |
ACTIVE
|
2.70
|
2.7
|
96956-8
|
Thinking about how you live: I have enough money to cope
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.R-OUTCOMES
| 4 |
Thinking about how you live: I have enough money to cope
| null | null |
ACTIVE
|
2.70
|
2.7
|
96957-6
|
SARS coronavirus 2 M gene
|
PrThr
|
Pt
|
Respiratory.upper
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) M gene [Presence] in Upper respiratory specimen by NAA with probe detection
|
SARS-CoV-2 M gene Upper resp Ql NAA+prb
| null |
ACTIVE
|
2.70
|
2.7
|
9695-8
|
3-Methoxy-4-Hydroxyphenylglycol
|
MRat
|
24H
|
Urine
|
Qn
| null |
CHEM
| 1 |
3-Methoxy-4-Hydroxyphenylglycol [Mass/time] in 24 hour Urine
|
3Me4OH-phenylglycol 24h Ur-mRate
| null |
ACTIVE
|
1.0i
|
2.73
|
96958-4
|
SARS coronavirus 2 N gene
|
PrThr
|
Pt
|
Saliva
|
Ord
|
Probe.amp.tar.CDC primer-probe set N2
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) N gene [Presence] in Saliva (oral fluid) by Nucleic acid amplification using CDC primer-probe set N2
|
SARS-CoV-2 N gene Sal Ql NAA N2
| null |
ACTIVE
|
2.70
|
2.7
|
96959-2
|
Cholesterol.in LDL.small dense
|
SCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
CHEM
| 1 |
Cholesterol.in LDL.small dense [Moles/volume] in Serum or Plasma
|
Chol.in LDL.small dense SerPl-sCnc
| null |
ACTIVE
|
2.70
|
2.7
|
969-6
|
D little u Ab
|
ACnc
|
Pt
|
Ser
|
Ord
|
Aggl RBC
|
BLDBK
| 1 |
Deprecated D little u Ab
|
Deprecated Du Ab Ser Ql
| null |
DEPRECATED
|
1.0
|
2.36
|
96960-0
|
Varicella zoster virus Ab.IgM Index
|
ACnc
|
Pt
|
Ser+CSF
|
Qn
| null |
MICRO
| 1 |
Varicella zoster virus IgM Ab index [Units/volume] in Serum and CSF
|
VZV IgM Index Ser+CSF-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
96961-8
|
Varicella zoster virus Ab.IgG Index
|
ACnc
|
Pt
|
Ser+CSF
|
Qn
| null |
MICRO
| 1 |
Varicella zoster virus IgG Ab index [Units/volume] in Serum and CSF
|
VZV IgG Index Ser+CSF-aCnc
| null |
ACTIVE
|
2.70
|
2.7
|
96962-6
|
Bordetella pertussis.pertussis toxin promoter region
|
PrThr
|
Pt
|
Respiratory.lower
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Bordetella pertussis.pertussis toxin promoter region [Presence] in Lower respiratory specimen by NAA with probe detection
|
B pert.PT Prmt Lower resp Ql NAA+probe
| null |
ACTIVE
|
2.70
|
2.7
|
96963-4
|
Grimontia holisae & Vibrio fluvialis & Vibrio harveyi DNA
|
Prid
|
Pt
|
XXX
|
Nom
|
Probe.amp.tar
|
MICRO
| 1 |
Grimontia holisae and Vibrio fluvialis and Vibrio harveyi DNA [Identifier] in Specimen by NAA with probe detection
|
G. hol + V. fluv + harv DNA Spec NAA+Prb
| null |
ACTIVE
|
2.70
|
2.7
|
96964-2
|
EZH2 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
EZH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
EZH2 gene Mut Anl Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96965-9
|
CARD11 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
CARD11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
CARD11 Mut Anl Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
9696-6
|
8-Hydroxyloxapine
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
8-Hydroxyloxapine [Mass/volume] in Serum or Plasma
|
8OH-Loxapine SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
96966-7
|
CD79A gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
CD79A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
CD79A Mut Anl Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96967-5
|
CD79B gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
CD79B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
CD79B Mut Anl Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96968-3
|
TNFAIP3 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
TNFAIP3 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
TNFAIP3 Mut Anl Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96969-1
|
MYD88 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.MUT
| 1 |
MYD88 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
MYD88 Mut Anl Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96970-9
|
TP53 gene deletion+duplication
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.DELDUP
| 1 |
TP53 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
TP53 gene Del+Dup Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96971-7
|
STK11 gene deletion+duplication
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.DELDUP
| 1 |
STK11 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
STK11 gene Del+Dup Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96972-5
|
PTEN gene deletion+duplication
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.DELDUP
| 1 |
PTEN gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
PTEN gene Del+Dup Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96973-3
|
CDH1 gene deletion+duplication
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.DELDUP
| 1 |
CDH1 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
CDH1 gene Del+Dup Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
9697-4
|
carBAMazepine 10,11-Epoxide
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
Deprecated carBAMazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma
|
Deprecated carBAMazepine EP SerPl-mCnc
| null |
DEPRECATED
|
1.0i
|
2.7
|
96974-1
|
PALB2 gene deletion+duplication
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
|
Molgen
|
MOLPATH.DELDUP
| 1 |
PALB2 gene deletion and duplication mutation analysis [Identifier] in Blood or Tissue by Molecular genetics method Nominal
|
PALB2 Del+Dup Bld/T
| null |
ACTIVE
|
2.70
|
2.7
|
96975-8
|
Sub-maximal exercise stress test study
|
Find
|
Pt
|
^Patient
|
Doc
|
{Role}
|
CARDIO-PULM
| 2 |
Sub-maximal exercise stress test study
|
SubMax Ex Stress Test
| null |
ACTIVE
|
2.70
|
2.72
|
96976-6
|
Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise
|
PPresDiff
|
Pt
|
Exhl gas
|
Qn
| null |
CARDIO-PULM
| 2 |
Carbon dioxide end tidal baseline - sub-maximal exercise delta
|
pCO2 baseline-SubMx Exer delta
| null |
ACTIVE
|
2.70
|
2.7
|
96977-4
|
Noninvasive prenatal fetal aneuploidy panel
|
-
|
Pt
|
WBC.DNA+Plas.cfDNA
|
-
|
Dosage of chromosome specific cf DNA
|
PANEL.MOLPATH
| 1 |
Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
|
NIP fet aneu Pnl WBC.DNA+cfDNA
| null |
ACTIVE
|
2.70
|
2.7
|
96978-2
|
Noninvasive prenatal fetal aneuploidy & 22q11.2 deletion panel
|
-
|
Pt
|
WBC.DNA+Plas.cfDNA
|
-
|
Dosage of chromosome specific cf DNA
|
PANEL.MOLPATH
| 1 |
Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
|
NIP aneu + 22q11.2 Pnl WBC.DNA+cfDNA
| null |
ACTIVE
|
2.70
|
2.7
|
96979-0
|
Fetal trisomy 13+trisomy 18+triploidy risk
|
Imp
|
Pt
|
WBC.DNA+Plas.cfDNA
|
Ord
|
Calculated
|
MOLPATH
| 1 |
Trisomy 13, trisomy 18 or triploidy risk [Interpretation] in Plasma cell-free+WBC DNA Qualitative by calculation
|
T13+T18+Trip risk WBC.DNA+cfDNA Calc-Imp
| null |
ACTIVE
|
2.70
|
2.7
|
96980-8
|
Comment on overall fetal aneuploidy risk
|
Txt
|
Pt
|
WBC.DNA+Plas.cfDNA
|
Nar
|
Dosage of chromosome specific cf DNA
|
MOLPATH
| 1 |
Comment on overall fetal aneuploidy risk [Text] in Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
|
Comment aneu risk WBC.DNA+cfDNA
| null |
ACTIVE
|
2.70
|
2.7
|
96981-6
|
Fetal trisomy 13+trisomy 18+triploidy risk
|
Likelihood
|
Pt
|
WBC.DNA+Plas.cfDNA
|
Qn
|
Calculated
|
MOLPATH
| 1 |
Trisomy 13, trisomy 18 or triploidy risk [Likelihood] in Plasma cell-free+WBC DNA by calculation
|
T13+T18+Trip risk WBC.DNA+cfDNA Calc
| null |
ACTIVE
|
2.70
|
2.7
|
9698-2
|
Desmethylclomipramine
|
MCnc
|
Pt
|
Ser
|
Qn
| null |
DRUG/TOX
| 1 |
Deprecated Norclomipramine [Mass/volume] in Serum or Plasma
|
Deprecated Desmethylclomipramine Ser
| null |
DEPRECATED
|
1.0i
|
2.7
|
96982-4
|
Test result delivery method
|
Type
|
Pt
|
Referral lab test
|
Nom
| null |
ADMIN
| 2 |
Referral lab test result delivery method
|
Ref lab result delivery method
| null |
ACTIVE
|
2.70
|
2.7
|
96983-2
|
Twin pregnancy
|
Find
|
Pt
|
^Patient
|
Ord
| null |
CLIN
| 2 |
Twin pregnancy
|
Twin pregnancy
| null |
ACTIVE
|
2.70
|
2.7
|
96984-0
|
Chromosome analysis
|
Find
|
Pt
|
POC
|
Doc
|
Microarray
|
MOLPATH
| 1 |
Chromosome analysis in Products of Conception by Microarray
|
Chrom analy POC Microarray
| null |
ACTIVE
|
2.70
|
2.7
|
96985-7
|
Fetal sex
|
Type
|
Pt
|
POC
|
Nom
|
Molgen
|
MOLPATH
| 1 |
Sex [Type] in Products of Conception by Molecular genetics method
|
Sex POC
| null |
ACTIVE
|
2.70
|
2.7
|
96986-5
|
SARS coronavirus 2 N gene
|
PrThr
|
Pt
|
Nose
|
Ord
|
Non-probe.amp.tar
|
MICRO
| 1 |
SARS-CoV-2 (COVID-19) N gene [Presence] in Nose by NAA with non-probe detection
|
SARS-CoV-2 N gene Nose Ql NAA+non-probe
| null |
ACTIVE
|
2.70
|
2.7
|
96987-3
|
Mass vaccination status
|
-
|
Pt
|
^Event
|
-
|
CDC.EOC
|
PANEL.SURVEY.CDC
| 4 |
Mass vaccination status [CDC Emergency Operations Centers]
| null | null |
ACTIVE
|
2.70
|
2.7
|
96988-1
|
CVX code
|
ID
|
Pt
|
Vaccine
|
Nom
| null |
VACCIN
| 2 |
Vaccine CVX code
|
Vaccine CVX code
| null |
ACTIVE
|
2.70
|
2.7
|
96989-9
|
MVX code
|
ID
|
Pt
|
Vaccine
|
Nom
| null |
VACCIN
| 2 |
Vaccine MVX code
|
Vaccine MVX code
| null |
ACTIVE
|
2.70
|
2.7
|
9699-0
|
PARoxetine
|
MCnc
|
Pt
|
Ser/Plas
|
Qn
| null |
DRUG/TOX
| 1 |
PARoxetine [Mass/volume] in Serum or Plasma
|
PARoxetine SerPl-mCnc
| null |
ACTIVE
|
1.0i
|
2.73
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.